Burning Rock Biotech Limited
- BNR
- NASDAQ
- Medical - Diagnostics & Research
- Cancer Diagnostics
- Molecular Diagnostics
$12.29
Today −4.73%Quote Oct 19, 2026, 08:00 PM UTC
−13.66%over the last month
Max drawdown −35.1%From 1-month high −35.1%3 months +30.1%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Burning Rock Biotech
Headquartered in Guangzhou, China, and established in 2014, Burning Rock Biotech Limited is primarily engaged in developing and providing diagnostic solutions for cancer therapy selection within the People's Republic of China. Its operations are structured across three key segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services.
Where the money comes from
Q4 2022 revenue $296.9M
- Service$206.0M69.4%
- Product$90.9M30.6%
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Exchange
NASDAQ
Employees
667
Market value
$13.0M
Quote Oct 19
Floor
$11.55
6.0% below price
Resistance
$13.95
13.5% above price
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about BNRPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free